| |
| |
|
| Insider
Information: |
Soffer Gad |
| Relationship: |
EVP & Chief Strategy O... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
243,966 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$129,278 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
243,966 |
|
|
| Total
Value |
$129,278 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP & Chief Strategy O... |
2018-09-22 |
243,966 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
12,400 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,239 |
114,639 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-05-15 |
4 |
D |
$37.30 |
$1,822,142 |
D/D |
(48,851) |
65,788 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$30,558 |
D/D |
16,538 |
82,326 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-08-17 |
4 |
AS |
$50.00 |
$438,900 |
D/D |
(8,778) |
73,548 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-08-18 |
4 |
AS |
$49.26 |
$381,626 |
D/D |
(7,711) |
65,837 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,762 |
79,599 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2015-11-17 |
4 |
AS |
$31.09 |
$236,846 |
D/D |
(7,586) |
72,013 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
48,447 |
120,460 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
134,221 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-02-17 |
4 |
AS |
$16.07 |
$95,786 |
D/D |
(5,711) |
128,510 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
142,271 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-05-17 |
4 |
AS |
$15.91 |
$86,344 |
D/D |
(5,427) |
136,844 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
150,605 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-08-16 |
4 |
AS |
$20.95 |
$120,040 |
D/D |
(5,356) |
145,249 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
235,249 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-14 |
4 |
AS |
$20.55 |
$196,910 |
D/D |
(9,582) |
225,667 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
239,428 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-16 |
4 |
AS |
$19.27 |
$137,511 |
D/D |
(7,136) |
232,292 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-17 |
4 |
AS |
$18.41 |
$27,247 |
D/D |
(1,480) |
230,812 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
275,812 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-10 |
4 |
AS |
$15.42 |
$97,029 |
D/D |
(6,274) |
269,538 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-14 |
4 |
AS |
$15.22 |
$106,540 |
D/D |
(7,000) |
262,538 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,762 |
276,300 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-16 |
4 |
AS |
$15.62 |
$113,604 |
D/D |
(7,273) |
269,027 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
